InflaRx NV (IFRX)
2.16
+0.10
(+4.85%)
USD |
NASDAQ |
Nov 22, 12:19
InflaRx Total Liabilities (Quarterly): 16.09M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.09M |
| June 30, 2024 | 11.66M |
| March 31, 2024 | 13.32M |
| December 31, 2023 | 19.48M |
| September 30, 2023 | 12.17M |
| June 30, 2023 | 9.04M |
| March 31, 2023 | 8.431M |
| December 31, 2022 | 15.07M |
| September 30, 2022 | 11.48M |
| June 30, 2022 | 13.06M |
| March 31, 2022 | 22.28M |
| December 31, 2021 | 22.48M |
| September 30, 2021 | 16.41M |
| June 30, 2021 | 13.58M |
| March 31, 2021 | 9.846M |
| December 31, 2020 | 12.73M |
| Date | Value |
|---|---|
| September 30, 2020 | 13.65M |
| June 30, 2020 | 14.34M |
| March 31, 2020 | 13.23M |
| December 31, 2019 | 16.16M |
| September 30, 2019 | 20.10M |
| June 30, 2019 | 15.98M |
| March 31, 2019 | 10.10M |
| December 31, 2018 | 8.949M |
| September 30, 2018 | 7.052M |
| June 30, 2018 | 4.416M |
| March 31, 2018 | 5.177M |
| December 31, 2017 | 5.739M |
| September 30, 2017 | 70.87M |
| June 30, 2017 | 67.77M |
| December 31, 2016 | 58.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.431M
Minimum
Mar 2023
22.48M
Maximum
Dec 2021
14.23M
Average
13.45M
Median
Total Liabilities (Quarterly) Benchmarks
| Affimed NV | 25.43M |
| BioNTech SE | 3.671B |
| Immatics NV | 217.47M |
| CureVac NV | 144.63M |
| ATAI Life Sciences NV | 51.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 89.00M |
| Shareholders Equity (Quarterly) | 72.91M |
| Current Ratio | 5.308 |